World Rare Disease Day 2018

posted on January 26, 2018
Since 2008, World Rare Disease Day is celebrated on the last day of February each year. This event aims to raise public awareness of rare diseases and promote engagement among patients, associations, researchers , decision-makers and other stakeholders. SOM Biotech, a private pharmaceutical company focused on drug repurposing for neurological rare diseases, will join in…
continue reading →

SOM Biotech at Biotech & Money Congress 2018

posted on January 26, 2018
SOM Biotech CEO, Dr. Raúl Insa, will attend the Biotech & Money Congress in London on 5th-7th of February. Dr. Insa will have the opportunity to present the company at the event and meet prospective investors and notable people in the industry. If you want to arrange a meeting with Dr. Insa, send an email…
continue reading →

Duchenne Parent Project España y SOM Biotech renuevan su acuerdo de colaboración

posted on January 24, 2018
Tras los resultados obtenidos durante el primer año de colaboración, la Asociación Duchenne Parent Project España (DPPE) confía nuevamente en la compañía Biofarmacéutica SOM Biotech prolongando el acuerdo de colaboración para llevar a cabo el proyecto “Reposicionamiento de Fármacos para la Distrofia Muscular de Duchenne (DMD)”. El equipo de SOM Biotech ha concluido satisfactoriamente la…
continue reading →

2017: A landmark year for SOM Biotech

posted on December 19, 2017
As 2017 comes to a close,  it is a great time of year for business to reflect on the achievements and the short comings versus the goals set out at the beginning of the year. This year has been a landmark year for SOM Biotech, shifting gear from an early stage company to growth phase…
continue reading →

World Orphan Drug Congress Europe 2017

posted on November 9, 2017
The 8th annual World Orphan Drug Congress was held in Barcelona on 13-15th of November 2017. SOM Biotech's CEO, Dr. Raúl Insa, did a “Pitch & Partner” session on Drug Repurposing in CNS Orphan Indications. The World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug…
continue reading →

SOM Biotech at Bio-Europe 2017

posted on October 31, 2017
Dr. Raúl Insa (CEO) and Raj Airey (Chief Strategy Officer) had the opportunity to discuss SOM’s current programs at Europe´s largest life science partnering conference Bio-Europe 2017,  that was held in Berlin November 6-9, 2017. BIO-Europe’s world-class workshops, panels and active exhibition along with thousands of pre-scheduled one-to-one meetings make this event an unrivaled forum…
continue reading →